Intended for healthcare professionals

Research News

Bipolar disorder: most patients receive suboptimal treatment, finds Scottish study

BMJ 2019; 364 doi: (Published 28 February 2019) Cite this as: BMJ 2019;364:l957
  1. Susan Mayor
  1. London

A quarter of patients with bipolar disorder in Scotland are treated with antidepressant monotherapy and do not receive lithium as recommended by the National Institute for Health and Care Excellence (NICE), a national data linkage study has shown.1

“Our findings suggest that most patients with bipolar disorder in Scotland are missing out on optimal treatments such as lithium and that many are receiving treatments such as antidepressant monotherapy that are at best ineffective and, at worse, detrimental for long term outcome,” warned the study authors, led by Daniel Smith, professor of psychiatry at …

View Full Text

Log in

Log in through your institution


* For online subscription